Oral and intravenous fosfomycin in complicated urinary tract infections

por López-Montesinos, Inmaculada, Horcajada, Juan P.
Publicado 2019

Ceftolozane-tazobactam: When, how and why using it?

por López, Inmaculada, Montesinos, Montero, Milagro, Sorlí, Luisa, Horcajada, Juan P.
Publicado 2021

Impact of changes in the WHO’s 2019 update of DDDs on the measurement of adult hospital antibacterial consumption in Catalonia (Spain), 2008–18

por Grau, Santiago, Hernández, Sergi, Limón, Enric, Calbo, Esther, Horcajada, Juan P
Publicado 2020

P27 Rezafungin treatment of candidaemia and invasive candidiasis: outcomes stratified by baseline renal function—analysis of the Phase 2 + Phase 3 trials

por Sandison, Taylor, Vazquez, Jose A, Honore, Patrick M, Soriano, Alex, Horcajada, Juan P, Slavin, Monica
Publicado 2023

2232. A Global Phase 3 Study of Delafloxacin (DLX) Compared with Moxifloxacin (MOX) in Patients with Community-acquired Bacterial Pneumonia (CABP)

por Salata, Robert, Alvarez-Sala, Rodolfo, Horcajada, Juan P, Lawrence, Laura, Quintas, Megan, Li, Yang, Cammarata, Sue
Publicado 2019

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli

por Esteve-Palau, Erika, Grau, Santiago, Herrera, Sabina, Sorlí1, Luisa, Montero, Milagro, Segura, Concha, Durán, Xavier, Horcajada, Juan P.
Publicado 2018

1236. Staphylococcus aureus Surgical Site Infection: Epidemiology in Europe (SALT)

por Mellinghoff, Sibylle, Bruns, Caroline, Albertrsmeier, Markus, Bassetti, Matteo, Horcajada, Juan P, Vehreschild, J Janne, Liss, Blasius J, Cornely, Oliver
Publicado 2019

1284. Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Cas...

por Thompson, George R, Horcajada, Juan P, Locke, Jeffrey B, Viani, Rolando, Pappas, Peter, Ghannoum, Mahmoud, Sandison, Taylor, Soriano, Alex
Publicado 2020

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort...

por Rozenkiewicz, Dawid, Esteve-Palau, Erika, Arenas-Miras, Mar, Grau, Santiago, Duran, Xavier, Sorlí, Luisa, Montero, María Milagro, Horcajada, Juan P.
Publicado 2021

A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)

por Horcajada, Juan P, Salata, Robert A, Álvarez-Sala, Rodolfo, Nitu, Floarea Mimi, Lawrence, Laura, Quintas, Megan, Cheng, Chun-Yen, Cammarata, Sue
Publicado 2019

A Descriptive Analysis of Urinary ESBL-Producing-Escherichia coli in Cerdanya Hospital

por Gaviria, Lorena Patrícia, Montsant, Lourdes, Azuaje, Carlos, González-Díaz, Aida, Horcajada, Juan P., Limón, Enric, Viñas, Miguel, Espinal, Paula, Fusté, Ester
Publicado 2022

Clinical, Microbiological and Treatment Characteristics of Severe Postoperative Respiratory Infections: An Observational Cohort Study

por Benítez-Cano, Adela, Bermejo, Silvia, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Zaragoza, Irene, Ramos, Isabel, Vallès, Jordi, Horcajada, Juan P., Adalia, Ramón
Publicado 2023

Invasive Cryptococcosis and Adalimumab Treatment

por Horcajada, Juan P., Peña, Jose L., Martínez-Taboada, Víctor M., Pina, Trinitario, Belaustegui, Isabel, Cano, María Eliecer, García-Palomo, Daniel, Fariñas, M. Carmen
Publicado 2007

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

por Sorlí, Luisa, Luque, Sonia, Grau, Santiago, Berenguer, Núria, Segura, Concepción, Montero, María Milagro, Álvarez-Lerma, Francisco, Knobel, Hernando, Benito, Natividad, Horcajada, Juan P
Publicado 2013

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

por Sorli, Luisa, Luque, Sonia, Li, Jian, Rodríguez, Eva, Campillo, Nuria, Fernandez, Xenia, Soldado, Jade, Domingo, Ignacio, Montero, Milagro, Grau, Santiago, Horcajada, Juan P.
Publicado 2019

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

por Morales, Eva, Cots, Francesc, Sala, Maria, Comas, Mercè, Belvis, Francesc, Riu, Marta, Salvadó, Margarita, Grau, Santiago, Horcajada, Juan P, Montero, Maria Milagro, Castells, Xavier
Publicado 2012

Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality

por de Pablo-Miró, Mar, Pujol-Ruiz, Sergi, Iftimie, Simona, Arenas-Miras, María del Mar, López-Montesinos, Inmaculada, Duran-Jordà, Xavier, Anglès, Albert, Grau, Santiago, Horcajada, Juan P.
Publicado 2021

Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study

por Bouza, Emilio, Cobo, Javier, Rodríguez-Hernández, Mª Jesús, Salavert, Miguel, Horcajada, Juan P, Iribarren, José Antonio, Obi, Engels, Lozano, Virginia, Maratia, Stefano, Cuesta, Maribel, Uría, Estefany, Limón, Enric
Publicado 2021

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial

por Villar-García, Judit, Güerri-Fernández, Robert, Moya, Andrés, González, Alicia, Hernández, Juan J., Lerma, Elisabet, Guelar, Ana, Sorli, Luisa, Horcajada, Juan P., Artacho, Alejandro, D´Auria, Giuseppe, Knobel, Hernando
Publicado 2017

ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa

por Puig-Collderram, Berta, Domene-Ochoa, Sandra, Salvà-Comas, Maria, Montero, Maria Milagro, Duran, Xavier, González, Juan R., Grau, Santiago, Oliver, Antonio, Horcajada, Juan P., Padilla, Eduardo, Segura, Concepción, Prim, Núria
Publicado 2022